Influenza experts pondering the relative failure of the H5N1 avian influenza virus to spread among humans believe that problems in monitoring the situation are made worse by the success of local poultry vaccination programs. Angus Nicoll, influenza project coordinator at the European Center for Disease Prevention and Control (ECDC), believes that low levels of the virus may be causing outbreaks, without the sudden deaths of large numbers of chickens or other farmed birds acting as warning signs.
An outbreak of human-transmitted bird flu on the Indonesian island of Sumatra in May prompted the World Health Organization to put its global stockpile of Swiss drug major Roche's Tamiflu (oseltamivir) on alert, however, the cluster was confined to a single family.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze